Back to AA Arax Advisory Partners
IPSC
5 quarters
Position history for AAArax Advisory Partners's holdings in Century Therapeutics, Inc.
Yes. Arax Advisory Partners holds 99 shares of IPSC (Century Therapeutics), worth $169, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Arax Advisory Partners has held IPSC since Q3 2025, across 5 quarterly 13F filings.
Current Value
$169
Current Shares
99
Total Value Change
+$120
Total Shares Change
0
Quarter-by-Quarter History